Dr. Deborah M. Longwill, DO, PA

Dr. Longwill practices at Deborah Longwill DO PA in Pinecrest, Florida.

Dr. Longwill's NPI, 1518921303, was assigned on April 17, 2006. Dr. Longwill graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1988. Dr. Longwill holds Florida license OS0005683.

Dr. Longwill's primary practice is Deborah Longwill DO PA, at 7700 Sw 104th St, Pinecrest, FL 33156 in Miami-Dade County. The practice phone is (305) 279-7546.

Dr. Longwill's primary practice is Deborah Longwill DO PA in Pinecrest, Florida. The medical group on file is Miami Center for Dermatology. Dmand AI also links Dr. Longwill to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Longwill practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Longwill's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Longwill is board certified in 1989 - 2026 by the FL State License. Dr. Longwill is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Longwill treats.

CMS data shows 5,740 Medicare services from Dr. Longwill across 22 procedure codes in 2024, for 767 Medicare patients. Medicare paid $340,827 for them. Every service was in an office.

CMS counts 767 Medicare patients who saw Dr. Longwill in 2024. The largest group is 65 to 74, with 433 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Longwill's median patient age at 47, with 61% women.

In 2024, Dr. Longwill wrote 793 Medicare Part D claims for 298 patients. 96% of them were for generic drugs. CMS names the drug for 682 of them, across 20 drugs with 11 or more claims each, at $17,613 in total drug cost. In 2023, CMS named 425 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Longwill for performance year 2024, reported as part of a group. Dr. Longwill accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,509 procedures of skin biopsy by Dr. Longwill, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Longwill in 2015. Dr. Longwill's most frequent co-authors are Joshua Davyd Fox, MD and Robert S. Kirsner, MD.

CMS Open Payments shows 221 general payments to Dr. Longwill from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Allergan Inc. paid the most, $2,317.

Dr. Longwill graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1988. Dr. Longwill is a member of AOA.

Dr. Longwill is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.